• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用放射性示踪剂抗-1-氨基-3-[¹⁸F]氟环丁烷-1-羧酸(抗-[¹⁸F]FACBC)与正电子发射断层扫描(PET)用于肾癌的初步经验。

Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinoma.

作者信息

Schuster David M, Nye Jonathon A, Nieh Peter T, Votaw John R, Halkar Raghuveer K, Issa Muta M, Yu Weiping, Sepulveda Julio, Zeng Wanzhen, Young Andrew, Goodman Mark M

机构信息

Department of Radiology, Division of Nuclear Medicine, Emory University, Atlanta, GA 30322, USA.

出版信息

Mol Imaging Biol. 2009 Nov-Dec;11(6):434-8. doi: 10.1007/s11307-009-0220-5. Epub 2009 May 16.

DOI:10.1007/s11307-009-0220-5
PMID:19449079
Abstract

PURPOSE

Assessment of renal masses with conventional imaging may be challenging. Anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid (anti-[18F]FACBC) is a synthetic L: -leucine analog with relatively little renal excretion. The present study examines anti-[(18)F]FACBC positron emission tomography uptake in patients with renal masses.

PROCEDURES

Six patients with seven renal lesions were imaged dynamically for 2 h after injection of 10-10.9 mCi (370-403 MBq) anti-[(18)F]FACBC. Lesions were evaluated qualitatively and quantitatively and correlated with histology.

RESULTS

Four clear cell and one Rosai-Dorfman lesion were hypo/isointense to normal cortex; two papillary lesions in the same patient were hyperintense. Mean SUV(max) +/- SD at 30 min was 2.8 +/- 0.24 for clear cell carcinomas and 4.5 +/- 1.7 for papillary cell lesions. Mean SUV(max)/SUV(mean) ratios +/- SD of lesion to normal cortex at 30 min was 1.15 +/- 0.19 for the clear cell carcinomas and 2.3 +/- 0.84 for papillary cell.

CONCLUSIONS

In this small patient sample, relative amino acid transport compared with renal cortex is elevated in renal papillary cell carcinoma but not in clear cell carcinoma.

摘要

目的

用传统成像方法评估肾肿块可能具有挑战性。抗1-氨基-3-[(18)F]氟环丁烷-1-羧酸(抗-[18F]FACBC)是一种合成的L-亮氨酸类似物,肾排泄相对较少。本研究检测肾肿块患者中抗-[(18)F]FACBC正电子发射断层扫描的摄取情况。

程序

6例患有7个肾病变的患者在注射10 - 10.9 mCi(370 - 403 MBq)抗-[(18)F]FACBC后进行了2小时的动态成像。对病变进行定性和定量评估,并与组织学进行关联。

结果

4例透明细胞癌和1例罗萨伊-多夫曼病变相对于正常皮质呈低/等密度;同一患者的2例乳头状病变呈高密度。透明细胞癌在30分钟时的平均SUV(max)±标准差为2.8±0.24,乳头状细胞病变为4.5±1.7。透明细胞癌在30分钟时病变与正常皮质的平均SUV(max)/SUV(mean)比值±标准差为1.15±0.19,乳头状细胞病变为2.3±0.84。

结论

在这个小样本患者中,与肾皮质相比,肾乳头状细胞癌中相对氨基酸转运升高,而透明细胞癌中未升高。

相似文献

1
Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinoma.用放射性示踪剂抗-1-氨基-3-[¹⁸F]氟环丁烷-1-羧酸(抗-[¹⁸F]FACBC)与正电子发射断层扫描(PET)用于肾癌的初步经验。
Mol Imaging Biol. 2009 Nov-Dec;11(6):434-8. doi: 10.1007/s11307-009-0220-5. Epub 2009 May 16.
2
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.放射性示踪剂抗1-氨基-3-18F-氟环丁烷-1-羧酸PET/CT用于前列腺癌的初步经验。
J Nucl Med. 2007 Jan;48(1):56-63.
3
Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions.抗 1-氨基-3-[(18)F]氟环丁烷-1-羧酸的合成 PET 氨基酸放射性示踪剂在无创性肺部病变成像中的初步研究。
Mol Imaging Biol. 2013 Oct;15(5):633-43. doi: 10.1007/s11307-012-0606-7.
4
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.应用抗 1-氨基-3-18F-氟环丁烷-1-羧酸 PET/CT 和 111In-标记的 capromab pendetide SPECT/CT 检测复发性前列腺癌。
Radiology. 2011 Jun;259(3):852-61. doi: 10.1148/radiol.11102023. Epub 2011 Apr 14.
5
Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.抗1-氨基-3-¹⁸F-氟环丁烷-1-羧酸:生理摄取模式、偶然发现以及可能模拟疾病的变异情况。
J Nucl Med. 2014 Dec;55(12):1986-92. doi: 10.2967/jnumed.114.143628. Epub 2014 Nov 13.
6
Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans.合成的非代谢氨基酸类似物抗-18F-FACBC在人体中的生物分布和辐射剂量测定。
J Nucl Med. 2007 Jun;48(6):1017-20. doi: 10.2967/jnumed.107.040097. Epub 2007 May 15.
7
Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors.用于脑肿瘤成像的[18F]1-氨基-3-氟环丁烷-1-羧酸的合成与评估
J Nucl Med. 1999 Feb;40(2):331-8.
8
The value of anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT in the diagnosis of recurrent prostate carcinoma: a meta-analysis.1-氨基-3-¹⁸F-氟环丁烷-1-羧酸正电子发射断层显像/计算机断层扫描(¹⁸F-FACBC PET/CT)在复发性前列腺癌诊断中的价值:一项荟萃分析
Acta Radiol. 2016 Apr;57(4):487-93. doi: 10.1177/0284185115581541. Epub 2015 Apr 22.
9
Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma.抗 1-氨基-2-[18F]氟环戊烷-1-羧酸(抗 2-[18F]FACPC)PET-CT 在复发性前列腺癌中的初步评估。
Mol Imaging Biol. 2011 Dec;13(6):1272-7. doi: 10.1007/s11307-010-0445-3.
10
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.抗3-[(18)F]氟代环丁基胞嘧啶正电子发射断层扫描-计算机断层扫描及(111)铟-卡铂单抗单光子发射计算机断层扫描-计算机断层扫描用于复发性前列腺癌:一项前瞻性临床试验的结果
J Urol. 2014 May;191(5):1446-53. doi: 10.1016/j.juro.2013.10.065. Epub 2013 Oct 19.

引用本文的文献

1
PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies.临床成人肿瘤学中的PET-CT-IV. 妇科和泌尿生殖系统恶性肿瘤
Cancers (Basel). 2022 Jun 18;14(12):3000. doi: 10.3390/cancers14123000.
2
Current and future perspectives on functional molecular imaging in nephro-urology: theranostics on the horizon.肾泌尿学中功能分子成像的当前与未来展望:即将到来的诊疗一体化
Theranostics. 2021 Apr 7;11(12):6105-6119. doi: 10.7150/thno.58682. eCollection 2021.
3
[F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis.

本文引用的文献

1
Renal cell carcinoma: imaging and therapy.肾细胞癌:影像学与治疗
Curr Opin Urol. 2007 Sep;17(5):337-40. doi: 10.1097/MOU.0b013e3282e7d87b.
2
Solid renal cortical tumors: differentiation with CT.实性肾皮质肿瘤:CT鉴别诊断
Radiology. 2007 Aug;244(2):494-504. doi: 10.1148/radiol.2442060927.
3
Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans.合成的非代谢氨基酸类似物抗-18F-FACBC在人体中的生物分布和辐射剂量测定。
[F]-氟代脱氧胸苷正电子发射断层扫描对复发性颅内转移性疾病与放射性坏死的鉴别诊断
EJNMMI Res. 2020 Dec 7;10(1):148. doi: 10.1186/s13550-020-00739-6.
4
[F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0.[F]氟代脱氧胸苷正电子发射断层扫描/计算机断层扫描:欧洲核医学与分子影像学会和美国核医学与分子影像学会联合制定的前列腺癌成像程序指南 - 第1.0版
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):579-591. doi: 10.1007/s00259-019-04614-y. Epub 2019 Dec 11.
5
Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.正电子发射断层扫描成像在代谢活跃型肾细胞癌中的作用。
Curr Urol Rep. 2019 Aug 29;20(10):56. doi: 10.1007/s11934-019-0932-2.
6
Imaging of distant metastases of prostate cancer.前列腺癌远处转移的影像学表现。
Med Oncol. 2018 Sep 14;35(11):148. doi: 10.1007/s12032-018-1208-2.
7
Update on F-Fluciclovine PET for Prostate Cancer Imaging.氟[^18^F]氟代脱氧葡萄糖 PET 用于前列腺癌成像的最新进展。
J Nucl Med. 2018 May;59(5):733-739. doi: 10.2967/jnumed.117.204032. Epub 2018 Mar 9.
8
PET-CT and PET-MR in urological cancers other than prostate cancer: An update on state of the art.除前列腺癌外的泌尿系统癌症中的PET-CT和PET-MR:最新技术进展
Indian J Urol. 2018 Jan-Mar;34(1):20-27. doi: 10.4103/iju.IJU_321_17.
9
PET Tracers Beyond FDG in Prostate Cancer.前列腺癌中除氟代脱氧葡萄糖之外的正电子发射断层显像示踪剂
Semin Nucl Med. 2016 Nov;46(6):507-521. doi: 10.1053/j.semnuclmed.2016.07.005. Epub 2016 Sep 7.
10
Update on advances in molecular PET in urological oncology.泌尿外科肿瘤分子正电子发射断层显像进展综述
Jpn J Radiol. 2016 Jul;34(7):470-85. doi: 10.1007/s11604-016-0553-3. Epub 2016 May 24.
J Nucl Med. 2007 Jun;48(6):1017-20. doi: 10.2967/jnumed.107.040097. Epub 2007 May 15.
4
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.放射性示踪剂抗1-氨基-3-18F-氟环丁烷-1-羧酸PET/CT用于前列腺癌的初步经验。
J Nucl Med. 2007 Jan;48(1):56-63.
5
A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer.用于检测前列腺癌的抗1-氨基-3-¹⁸F-氟环丁烷-1-羧酸的初步研究。
J Nucl Med. 2007 Jan;48(1):46-55.
6
Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging.术前影像学检查推测为肾细胞癌的孤立性肾肿块行部分肾切除术时良性病理结果的发生率。
Urology. 2006 Oct;68(4):737-40. doi: 10.1016/j.urology.2006.04.011.
7
Cancer statistics, 2006.2006年癌症统计数据。
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
8
Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters.
AJR Am J Roentgenol. 2004 Nov;183(5):1387-91. doi: 10.2214/ajr.183.5.1831387.
9
Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma.氟脱氧葡萄糖F 18正电子发射断层扫描在肾细胞癌检测中的临床应用。
J Urol. 2004 May;171(5):1806-9. doi: 10.1097/01.ju.0000120241.50061.e4.
10
Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis.抗[18F]FACBC的合成改进:标记前体的制备改进及自动化放射性合成
Appl Radiat Isot. 2003 Jun;58(6):657-66. doi: 10.1016/s0969-8043(03)00029-0.